| Autor: |
Kavyasudha C; Department of Genetic Engineering, SRM Institute of Science and Technology, Chennai, India., Macrin D; Department of Genetic Engineering, SRM Institute of Science and Technology, Chennai, India., ArulJothi KN; Department of Genetic Engineering, SRM Institute of Science and Technology, Chennai, India., Joseph JP; Department of Genetic Engineering, SRM Institute of Science and Technology, Chennai, India., Harishankar MK; Department of Genetic Engineering, SRM Institute of Science and Technology, Chennai, India., Devi A; Department of Genetic Engineering, SRM Institute of Science and Technology, Chennai, India. adevipradeep@gmail.com. |
| Abstrakt: |
In an adult human body, somatic stem cells are present in small amounts in almost all organs with the function of general maintenance and prevention of premature aging. But, these stem cells are not pluripotent and are unable to regenerate large cellular loss caused by infarctions or fractures especially in cells with limited replicative ability such as neurons and cardiomyocytes. These limitations gave rise to the idea of inducing pluripotency to adult somatic cells and thereby restoring their regeneration, replication and plasticity. Though many trials and research were focused on inducing pluripotency, a solid breakthrough was achieved by Yamanaka in 2006. Yamanaka's research identified 4 genes (OCT-4, SOX-2, KLF-4 and c-MYC) as the key requisite for inducing pluripotency in any somatic cells (iPSCs). Our study, reviews the major methods used for inducing pluripotency, differentiation into specific cell types and their application in both cell regeneration and disease modelling. We have also highlighted the current status of iPSCs in clinical applications by analysing the registered clinical trials. We believe that this review will assist the researchers to decide the parameters such as induction method and focus their efforts towards clinical application of iPSCs. |
